乙型肝炎患者中的 HCC:亚太地区的考虑

在这些幻灯片中,专家教员讨论了与乙型肝炎环境中的 HCC 患者相关的亚太地区注意事项。
Grace LH Wong, 医学博士
Format: Microsoft PowerPoint (.ppt)
File Size: 704 KB
Released: June 18, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Dr. Paul Y. Kwo discusses his take on the importance of universal screening of all patients with hepatitis B virus (HBV) for hepatitis delta virus (HDV), from Clinical Care Options (CCO)

Paul Y. Kwo, MD Released: December 3, 2021

Clinical Care Options (CCO) expert analysis by Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 3, 2021

Clinical Care Options (CCO) podcast with Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 1, 2021

Clinical Care Options (CCO) expert analysis by Dr. Stefan Zeuzem on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Stefan Zeuzem, MD Released: November 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue